Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease

NCT03179501 is registered in ClinicalTrials.gov with Beau Nakamoto as lead sponsor.

NCT NCT03179501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03179501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease
Lead sponsor
Beau Nakamoto
Phase
Phase 1
Overall status
Terminated
Start date
September 1, 2017
Completion date
July 31, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease